This brief summarizes and updates results of the Quality of Official Development Assistance (QuODA) index applied to health aid and compares these results to the overall QuODA assessment. Through quantifying performance on aid effectiveness, we hope to motivate improvements in health aid effectiveness and contribute to the definition of better, more empirically based measures of health aid quality.
This paper examines opportunities for improved efficiency in malaria control, analyzing the effectiveness of interventions and current trends in spending. Overall, it appears that resources for malaria control are well spent—however, there remain areas for improved efficiency, including (i) improving procurement procedures for bed nets, (ii) developing efficient ways to replace bed nets as they wear out, (iii) reducing overlap of spraying and bed net programs, (iv) expanding the use of rapid diagnostics, and (v) scaling up intermittent presumptive treatment for pregnant women and infants.
In this joint report, Thomas J. Bollyky, CFR senior fellow for global health, economics, and development, and Amanda Glassman, director of global health policy at the Center for Global Development, propose applying Cash-on-Delivery (COD) Aid as a new incentive mechanism for tobacco control in low- and middle-income countries.
Jacob Hughes, Amanda Glassman, and Walter Gwenigale discuss the design, opportunities, and limitations of the of Liberia Health Sector Pool Fund.
The authors apply Birdsall and Kharas’s Quality of Official Development Assistance (QuODA) methodology to rank donors across 23 indicators of aid effectiveness in health.
Data Set for Working Paper 287: “An Index of the Quality of Official Development Assistance in Health”
This data set allows replication of the results in CGD Working Paper 287, An Index of the Quality of Official Development Assistance in Health.
As the Global Health Initiative moves into its third year of implementation, Nandini Oomman and Rachel Silverman summarize the current status of this major development initiative, highlight the challenges for the GHI, and propose specific recommendations for a way forward.
This report of the Rethinking U.S. Foreign Assistance Program summarizes the rationale for continued U.S. investment in global health, looks into the evolution of the Global Health Initiative, and recommends a re-boot for the whole enterprise.
Global Health and the New Bottom Billion: How Funders Should Respond to Shifts in Global Poverty and Disease Burden
After a decade of rapid economic growth, many developing countries have attained middle-income status, but poverty reduction in these countries has not kept pace with economic growth. Most of the world’s poor—up to a billion people—now live in these new middle-income countries. These countries also carry the majority of the global disease burden.
This brief summarizes the recommendations in Achieving an AIDS Transition to use focused policies and well-designed incentives to finally bring the AIDS epidemic under control.
Safer, Faster, Cheaper: Improving Clinical Trials and Regulatory Pathways to Fight Neglected Diseases (CGD Brief)
This brief outlines the recommendations from the report of the Center for Global Development’s Working Group on Clinical Trials and Regulatory Pathways
Safer, Faster, Cheaper: Improving Clinical Trials and Regulatory Pathways to Fight Neglected Diseases
This report of the Working Group on Clinical Trials and Regulatory Pathways provides practical policy recommendations to help provide better, safer, and cheaper medicine and treatment to the 1 billion people suffering from neglected diseases.
Global Health and the New Bottom Billion: What Do Shifts in Global Poverty and the Global Disease Burden Mean for GAVI and the Global Fund? - Working Paper 270
After a decade of rapid growth in average incomes, many countries have attained middle-income country (MIC) status, while poverty hasn’t fallen as much as one might expect. As a result, there are up to a billion poor people or a ‘new bottom billion’ living not in the world’s poorest countries but in MIC. Not only has the global distribution of poverty shifted to MIC, so has the global disease burden. The paper describes trends in the global distribution of poverty, preventable infectious diseases, and health aid response to date and proposes a new MIC strategy and components, concluding with recommendations.
Noncommunicable diseases (NCDs) such as cancer, diabetes, respiratory and cardiovascular diseases, and mental illnesses are the leading cause of death and disability worldwide. The good news is that much of the NCD burden can be prevented through interventions that are affordable in most countries. The United States can help now by taking five low-cost or no-cost steps.
The Health Systems Funding Platform: Resolving Tensions between the Aid and Development Effectiveness Agendas - Working Paper 258
This paper briefly assesses the Health Systems Funding Platform and finds that its progress differs little from prior initiatives, although it does present an opportunity to make global health aid more effective.
GAVI’s Future: Steps to Build Strategic Leadership, Financial Sustainability, and Better Partnerships
As GAVI and its new leadership look beyond June 13, Amanda Glassman of CGD and Lisa Carty, Margaret Reeves and Stephen Morrison of CSIS have joined to recommend an agenda that builds on GAVI’s comparative advantage and maximizes impact on child health.
The Best Things in Life are (Nearly) Free: Technology, Knowledge and Global Health - Working Paper 252
In this paper, background to Kenny’s book Getting Better, the authors investigate the cross-country determinants of health improvements and describe the implications for development policy.
The time is right to reinvigorate UNFPA. Seventeen years after the groundbreaking ICPD meeting, UNFPA needs to make itself the lead agency for population, sexual and reproductive health, and reproductive rights in the UN system, as well as be more visible externally.